James Hambro & Partners LLP Decreases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

James Hambro & Partners LLP reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 242,622 shares of the medical equipment provider's stock after selling 2,187 shares during the quarter. Intuitive Surgical comprises 5.0% of James Hambro & Partners LLP's investment portfolio, making the stock its 7th biggest position. James Hambro & Partners LLP owned about 0.07% of Intuitive Surgical worth $126,664,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $38,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Down 1.8 %

Shares of NASDAQ ISRG traded down $10.57 during trading on Monday, reaching $573.48. The company had a trading volume of 2,439,219 shares, compared to its average volume of 2,023,604. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business's 50-day moving average is $547.16 and its 200 day moving average is $505.21. The stock has a market cap of $204.26 billion, a PE ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 42,453 shares of company stock valued at $22,059,506. 0.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research analyst reports. UBS Group upped their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday. Bernstein Bank raised their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday. Finally, BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.